Replies to post #195980 on Biotech Values

[DewDiligence]

Soundbite from AMGN’s VP of Biosimilars (at Barclays webcast 10/7/15):

“The FDA has started to stop moving the goalposts.”

I understand what it means, but it sounds like something Yogi Berra might have said.